dad - senior scientist at pennlinc.io - psychedelics and other fun stuff - aspiring urban homesteader - sypres.io
Joined March 2018
- Tweets 4,020
- Following 1,165
- Followers 1,905
- Likes 7,271
660 Photos and videos
Pinned Tweet
π Our first sypres.io living systematic review and meta-analysis on psilocybin for depression is out now in @NatMentHealth. Here's what we found and the open science infrastructure we built to support it: π§΅
Open-Access Link: rdcu.be/fbU5V
2
8
23
2,613
Parker Singleton retweeted
May 14
a very clear articulation of synergy in the brain and why it's key for human-level cognition and consciousness from @loopyluppi
May 13
Brain synergy is a balance between neurons transmitting signals between each other and neurons not communicating at all; a balance of integration and segregation. What's fascinating about human brain is that evolutionary, it only grew in places that had the most synergy, and those places are not random. Meaning, you can't just enlarge a chimp's brain and get a human brain. This synergy might be key to deciphering both consciousness and cognition.
9
47
4,703
Parker Singleton retweeted
May 5
hey mind reviewing these real quick
115
82
2,746
286,726
Nice article on our recent Nature Mental Health paper: medscape.com/viewarticle/livβ¦
3
141
Parker Singleton retweeted
Apr 25
NY Post finding out about Asheville crust punks in Year of Our Lord 2026
Apr 25
Once-charming, US mountain escape has transformed into 'nasty, crazy, and scary' city trib.al/jpSrLJ6
27
93
1,602
188,943
Parker Singleton retweeted
Apr 19
Diffusion MRI (dMRI) is a powerful tool to study white matter maturation. In our new preprint, we process and distribute a new resource of >24,000 ABCD dMRI scans using open source tools! We then evaluate how methods shape inferences about development.
π bit.ly/3QMLG0K
2
33
97
8,239
Parker Singleton retweeted
Incredible work by the absolutely stellar Brooke Sevchick and @singletonion β the second installment of our open-science living meta-analysis of psychedelics for mental health; check out sypres.io.
π Our second installment of sypres.io, a living systematic review and meta-analysis on MDMA for PTSD is now live on medRxiv. Here's what we found and how we built upon our open science infrastructure to support it π§΅
medrxiv.org/content/10.64898β¦
3
9
1,311
π Our second installment of sypres.io, a living systematic review and meta-analysis on MDMA for PTSD is now live on medRxiv. Here's what we found and how we built upon our open science infrastructure to support it π§΅
medrxiv.org/content/10.64898β¦
1
7
23
2,944
In partnership with metapsy.org, we built an interactive dashboard for exploring the data. Users can:
β’ Filter studies by characteristics
β’ Test different analysis parameters
β’ Test moderators
β’ Download figures and reports
Dashboard: metapsy.org/sypres/mdma-ptsd
1
3
87
Huge shout out to co-first author Brooke Sevchik, Analiese Lahey, Pim Cuijpers, @MathiasHarrer, Megan Jones, @sdpnayak, Eric Strain, @VandyAtVandy, @ExistWell, Bob Dworkin, Cobb Scott, and @sattertt.
4
96
Parker Singleton retweeted
Apr 6
Two systematic, meta-analyses on psychedelic drugs today
Brain Circuit Function @NatureMedicine
nature.com/articles/s41591-0β¦
Depression @NatMentHealth
nature.com/articles/s44220-0β¦
7
33
142
23,977
Parker Singleton retweeted
Beyond delighted to see this paper -- our first from the SYPRES initiative -- now out at Nature Mental Health. Check out Parker's awesome explainer below, w/ links to dashboard all code data.
π Our first sypres.io living systematic review and meta-analysis on psilocybin for depression is out now in @NatMentHealth. Here's what we found and the open science infrastructure we built to support it: π§΅
Open-Access Link: rdcu.be/fbU5V
6
7
1,367
π Our first sypres.io living systematic review and meta-analysis on psilocybin for depression is out now in @NatMentHealth. Here's what we found and the open science infrastructure we built to support it: π§΅
Open-Access Link: rdcu.be/fbU5V
2
8
23
2,613
We recently added all of the above resources accompanying our second installment on MDMA for PTSD symptoms, currently a pre-print: medrxiv.org/content/10.64898β¦
1
2
88
Huge shout out to co-first author Brooke Sevchik, Analiese Lahey, Pim Cuijpers, @MathiasHarrer, Megan Jones, @sdpnayak, Eric Strain, @VandyAtVandy, Bob Dworkin, Cobb Scott, and @sattertt.
2
96